| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | CGK 733 |
|---|
| Description | Originally defined as a selective inhibitor of ATR and ATM kinases. Induces cell death in prematurely senescent breast cancer cells. Decreases p21CIP1 levels in premature senescent MCF-7 and HCT-116 cells; also exhibits antiproliferative activity in a range of cancer cell lines. Blocks camptothecin-induced p53 phosphorylation and protects cells from camptothecin-induced apoptosis. Purity 98%. MW (observed): 555.84 |
|---|
| Size | 10 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | α-Phenyl-N-[2,2,2-trichloro-1-[[[(4-fluoro-3-nitrophenyl)amino]thioxomethyl]amino]ethyl]benzeneacetamide |
|---|
| Gene, Accession, CAS # | CAS: 905973-89-9 |
|---|
| Catalog # | 2639/10 |
|---|
| Price | |
|---|
| Order / More Info | CGK 733 from TOCRIS BIOSCIENCE
|
|---|
| Product Specific References | PubMed: 21680529, 24247150, 26097382 |
|---|
| 產(chǎn)品資料 |
|
|